Metabolism

Items 41-50 of 145

per page
Set Descending Direction
  1. DLL3 (human) (rec.)
    AG-40B-0151
    AG-40B-0151-C01010 µg
    CHF 215.00
    AG-40B-0151-30103 x 10 µg
    CHF 430.00
  2. DLL4 (human):Fc (human) (rec.) (highly active mutant)
    AG-40B-0176
    AG-40B-0176-C01010 µg
    CHF 350.00
    AG-40B-0176-C100100 µg
    CHF 1'080.00
    DLL4 (human):Fc (human) (rec.) (highly active mutant) (AG-40B-0176) binds to mNotch1 with higher affinity than WT DLL4:Fc. Method: Notch1 (mouse):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations
  3. DNER (extracellular domain) (human) (rec.)
    AG-40A-0137Y
    AG-40A-0137Y-C01010 µg
    CHF 265.00
    AG-40A-0137Y-30103 x 10 µg
    CHF 530.00
  4. DNER (extracellular domain) (human):Fc (human) (rec.)
    AG-40A-0119T
    AG-40A-0119T-C01010 µg
    CHF 170.00
    AG-40A-0119T-C05050 µg
    CHF 470.00
  5. DNER (extracellular domain) (mouse):Fc (human) (rec.)
    AG-40A-0177
    AG-40A-0177-C01010 µg
    CHF 230.00
    AG-40A-0177-C05050 µg
    CHF 685.00
  6. EPO (human):Fc (human) (rec.) (non-lytic)
    CHI-HF-220EPO
    CHI-HF-220EPO-C05050 µg
    CHF 430.00
  7. FABP1 (human) (rec.) (His)
    AG-40A-0039T
    AG-40A-0039T-C05050 µg
    CHF 350.00
    Replaces AG-40A-0039
  8. FABP3 (human) (rec.) (untagged)
    AG-40B-6002
    AG-40B-6002-C05050 µg
    CHF 350.00
  9. FABP4 (human) (rec.) (His)
    AG-40A-0035
    AG-40A-0035-C05050 µg
    CHF 250.00
  10. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper

Items 41-50 of 145

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.